A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Compare the Efficacy and Safety of Denosumab Versus Placebo in Males With Low Bone Mineral Density.

Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Compare the Efficacy and Safety of Denosumab Versus Placebo in Males With Low Bone Mineral Density.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2015

At a glance

  • Drugs Denosumab (Primary)
  • Indications Bone resorption; Male osteoporosis
  • Focus Registrational; Therapeutic Use
  • Acronyms ADAMO
  • Sponsors Amgen
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 Oct 2013 Results of the transiliac crest bone biopsy substudy (n=29) presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
    • 14 Nov 2012 One-year outcomes presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top